David De Bels

3.3k total citations
81 papers, 1.0k citations indexed

About

David De Bels is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David De Bels has authored 81 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 20 papers in Epidemiology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David De Bels's work include Mechanical Circulatory Support Devices (15 papers), Respiratory Support and Mechanisms (13 papers) and Sepsis Diagnosis and Treatment (9 papers). David De Bels is often cited by papers focused on Mechanical Circulatory Support Devices (15 papers), Respiratory Support and Mechanisms (13 papers) and Sepsis Diagnosis and Treatment (9 papers). David De Bels collaborates with scholars based in Belgium, United States and France. David De Bels's co-authors include Patrick M. Honoré, Costantino Balestra, Rachid Attou, Peter Germonpré, A.M. Korinek, Louis Puybasset, Francis Corazza, Sébastien Redant, Anne‐Laure Boch and Jacques Devriendt and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Applied Physiology.

In The Last Decade

David De Bels

75 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David De Bels Belgium 18 206 202 186 157 156 81 1.0k
Alexy Tran‐Dinh France 19 85 0.4× 336 1.7× 147 0.8× 361 2.3× 224 1.4× 87 1.2k
Helena Chang United States 17 92 0.4× 219 1.1× 179 1.0× 301 1.9× 36 0.2× 36 1.3k
Dominik Jarczak Germany 18 123 0.6× 478 2.4× 214 1.2× 170 1.1× 279 1.8× 56 1.3k
Alice G. Vassiliou Greece 20 240 1.2× 225 1.1× 253 1.4× 78 0.5× 333 2.1× 96 1.2k
Peter Bentzer Sweden 23 333 1.6× 458 2.3× 173 0.9× 431 2.7× 122 0.8× 83 1.6k
Fanny Vardon‐Bounes France 16 120 0.6× 237 1.2× 121 0.7× 114 0.7× 144 0.9× 58 917
Philipp Eller Austria 22 64 0.3× 506 2.5× 266 1.4× 418 2.7× 347 2.2× 94 2.0k
Kazuhisa Yoshiya Japan 17 177 0.9× 201 1.0× 95 0.5× 175 1.1× 208 1.3× 44 1.1k
Baoli Cheng China 25 88 0.4× 519 2.6× 356 1.9× 307 2.0× 121 0.8× 57 1.9k
İsmail Koçyiğit Türkiye 22 117 0.6× 158 0.8× 249 1.3× 212 1.4× 59 0.4× 145 1.6k

Countries citing papers authored by David De Bels

Since Specialization
Citations

This map shows the geographic impact of David De Bels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David De Bels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David De Bels more than expected).

Fields of papers citing papers by David De Bels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David De Bels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David De Bels. The network helps show where David De Bels may publish in the future.

Co-authorship network of co-authors of David De Bels

This figure shows the co-authorship network connecting the top 25 collaborators of David De Bels. A scholar is included among the top collaborators of David De Bels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David De Bels. David De Bels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dauby, Nicolás, Evelyne Maillart, Jean‐François Fils, et al.. (2022). Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6. Viral Immunology. 35(1). 60–70. 6 indexed citations
2.
Theunissen, Sigrid, et al.. (2022). Effects of Acute Hypobaric Hypoxia Exposure on Cardiovascular Function in Unacclimatized Healthy Subjects: A “Rapid Ascent” Hypobaric Chamber Study. International Journal of Environmental Research and Public Health. 19(9). 5394–5394. 10 indexed citations
3.
Attou, Rachid, et al.. (2021). Management of late onset urea cycle disorders—a remaining challenge for the intensivist?. Annals of Intensive Care. 11(1). 2–2. 19 indexed citations
4.
Debaugnies, France, Bhavna Mahadeb, Carole Nagant, et al.. (2021). Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients. Journal of Clinical Immunology. 41(3). 658–665. 28 indexed citations
5.
Bels, David De, et al.. (2021). Prone positioning in coronavirus disease 2019 patients with acute respiratory distress syndrome: How and when is the best way to do it?. Journal of Translational Internal Medicine. 9(2). 65–67. 3 indexed citations
6.
7.
Pierrakos, Charalampos, David De Bels, Thomas Nguyen, et al.. (2021). Changes in central venous-to-arterial carbon dioxide tension induced by fluid bolus in critically ill patients. PLoS ONE. 16(9). e0257314–e0257314. 5 indexed citations
8.
Bels, David De, Francis Corazza, Mariano Bizzarri, et al.. (2020). Hyperoxia Alters Ultrastructure and Induces Apoptosis in Leukemia Cell Lines. Biomolecules. 10(2). 282–282. 13 indexed citations
9.
Nguyen, Thomas, et al.. (2020). A case of Takotsubo cardiomyopathy with COVID 19. European Heart Journal - Cardiovascular Imaging. 21(9). 1052–1052. 35 indexed citations
10.
Honoré, Patrick M., et al.. (2020). Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not. Critical Care. 24(1). 553–553. 12 indexed citations
11.
Bels, David De, et al.. (2020). Potassium disorders in pediatric emergency department: Clinical spectrum and management. Archives de Pédiatrie. 27(3). 146–151. 3 indexed citations
12.
Bels, David De, et al.. (2019). Elevated lactic acid during ketoacidosis: pathophysiology and management. Journal of Translational Internal Medicine. 7(3). 115–117. 9 indexed citations
13.
Bels, David De, et al.. (2019). Angiotensin converting enzyme inhibitor intoxication: Naloxone to the rescue? Naloxone for ACE inhibitor intoxication. The American Journal of Emergency Medicine. 37(6). 1217.e1–1217.e2. 3 indexed citations
14.
Redant, Sébastien, François Angoulvant, Patrick M. Honoré, et al.. (2019). Unknown use of end-tidal CO2 in metabolic emergencies in pediatric patients. Journal of Translational Internal Medicine. 7(2). 76–78. 1 indexed citations
15.
Bels, David De, et al.. (2014). Fatal multiple coronary involvements in a young woman with systemic lupus erythematosus. Acta Clinica Belgica. 69(6). 460–462. 2 indexed citations
16.
Bels, David De, et al.. (2012). Torsade de pointes in Kearns–Sayre syndrome. Practical Neurology. 12(3). 199–201. 10 indexed citations
17.
Lytrivi, Maria, et al.. (2011). Rhabdomyolysis-induced acute renal failure due to itraconazole and simvastatin association. Drug metabolism and drug interactions. 26(2). 79–80. 7 indexed citations
18.
Theunissen, Sigrid, David De Bels, Jacques Devriendt, et al.. (2011). The normobaric oxygen paradox: does it increase haemoglobin?. Critical Care. 15(S1). 67–71. 18 indexed citations
19.
Bels, David De, A.M. Korinek, Régis Bismuth, et al.. (2002). Empirical Treatment of Adult Postsurgical Nosocomial Meningitis. Acta Neurochirurgica. 144(10). 989–995. 1 indexed citations
20.
Bels, David De, A.M. Korinek, Régis Bismuth, et al.. (2002). Empirical Treatment of Adult Postsurgical Nosocomial Meningitis. Acta Neurochirurgica. 144(10). 989–995. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexy Tran‐Dinh Breakdown of academic impact, for papers by Helena Chang Breakdown of academic impact, for papers by Dominik Jarczak Breakdown of academic impact, for papers by Alice G. Vassiliou Breakdown of academic impact, for papers by Peter Bentzer Breakdown of academic impact, for papers by Fanny Vardon‐Bounes Breakdown of academic impact, for papers by Philipp Eller Breakdown of academic impact, for papers by Kazuhisa Yoshiya Breakdown of academic impact, for papers by Baoli Cheng Breakdown of academic impact, for papers by İsmail Koçyiğit
Rankless by CCL
2026